Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : AP-003
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : BetterLife Pharma
Deal Size : Undisclosed
Deal Type : Agreement
BetterLife Scales up Manufacturing of AP-003 (Interferon Alpha 2b) to Prepare for Clinical Trials
Details : Under the terms of the agreement, List Labs will provide manufacturing services from its state-of-the-art biological development and cGMP manufacturing facility in Campbell, California.
Brand Name : AntiCovir
Molecule Type : Large molecule
Upfront Cash : Undisclosed
September 17, 2020
Lead Product(s) : AP-003
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : BetterLife Pharma
Deal Size : Undisclosed
Deal Type : Agreement
LOOKING FOR A SUPPLIER?